Short-term societal economic burden of first-incident type 2 diabetes-related complications – a nationwide cohort study

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019 Nov;157:107843.
   PubMed Web of Science ®Google Scholar
• The register of selected chronic diseases and severe mental disorders. Danish Health Data Authority; 2020 [cited 2020 May]. Available from: https://www.esundhed.dk/Registre/Register-for-udvalgte-kroniske-sygdomme
   Google Scholar
• Rawshani A, Rawshani A, Franzen S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017 Apr 13;376(15):1407–1418.
   PubMed Web of Science ®Google Scholar
• Carstensen B, Rønn PF, Jørgensen ME. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016. BMJ Open Diabetes Res Care. 2020 May;8(1):e001071.
   Web of Science ®Google Scholar
• Sortso C, Green A, Jensen PB, et al. Societal costs of diabetes mellitus in Denmark. Diabet Med. 2016 Jul;33(7):877–885.
   PubMed Web of Science ®Google Scholar
• Hex N, Bartlett C, Wright D, et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012 Jul;29(7):855–862.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
   PubMed Web of Science ®Google Scholar
• Andersen JS, Olivarius Nde F, Krasnik A. The Danish National health service register. Scand J Public Health. 2011 Jul;39(7 Suppl):34–37.
   PubMed Web of Science ®Google Scholar
• Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, et al. Data resource profile: the Danish National prescription registry. Int J Epidemiol. 2017 Jun 1;46(3):798–798f.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014 Aug;29(8):541–549.
   PubMed Web of Science ®Google Scholar
• Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011 Jul;39(7 Suppl):103–105.
   PubMed Web of Science ®Google Scholar
• Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011 Jul;39(7 Suppl):91–94.
   PubMed Web of Science ®Google Scholar
• Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011 Jul;39(7 Suppl):95–98.
   PubMed Web of Science ®Google Scholar
• Den samfundsøkonomiske diskonteringsrente. Danish Ministry of Finance; 2018 [cited 2019 Oct]. Available from: https://www.fm.dk/oekonomi-og-tal/finansministeriets-regnemetoder
   Google Scholar
• Alva ML, Gray A, Mihaylova B, et al. The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med. 2015 Apr;32(4):459–466.
   PubMed Web of Science ®Google Scholar
• Danese MD, Gleeson M, Kutikova L, et al. Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK. BMJ Open. 2016 Aug 5;6(8):e011805.
   PubMed Web of Science ®Google Scholar
• Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):487–497.
   PubMed Web of Science ®Google Scholar
• Ward A, Alvarez P, Vo L, et al. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012). J Med Econ. 2014 Mar;17(3):176–183.
   PubMedGoogle Scholar
• Mata-Cases M, Rodríguez-Sánchez B, Mauricio D, et al. The association between poor glycemic control and health care costs in people with diabetes: a population-based study. Diabetes Care. 2020 Apr;43(4):751–758.
   PubMed Web of Science ®Google Scholar
• Ng CS, Lee JY, Toh MP, et al. Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2014 Aug;105(2):151–163.
   PubMed Web of Science ®Google Scholar
• Leal J, Luengo-Fernández R, Gray A, et al. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006 Jul;27(13):1610–1619.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Sánchez B, Cantarero-Prieto D. Performance of people with diabetes in the labor market: an empirical approach controlling for complications. Econ Hum Biol. 2017 Nov;27(Pt A):102–113.
   PubMed Web of Science ®Google Scholar
• Jakobsen M, Kolodziejczyk C, Fredslund EK, et al. Societal costs of first-incident ischemic stroke in patients with atrial fibrillation-a Danish Nationwide Registry study. Value Health. 2016 Jun;19(4):413–418.
   PubMed Web of Science ®Google Scholar
• Jakobsen M, Kolodziejczyk C, Klausen Fredslund E, et al. Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study. BMC Health Serv Res. 2017 Jun 12;17(1):398.
   PubMed Web of Science ®Google Scholar
• Johnsen SP, Dalby LW, Täckström T, et al. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017 Nov 10;17(1):714.
   PubMed Web of Science ®Google Scholar
• Pedron S, Emmert-Fees K, Laxy M, et al. The impact of diabetes on labour market participation: a systematic review of results and methods. BMC Public Health. 2019 Jan 7;19(1):25.
   PubMed Web of Science ®Google Scholar
• Sørensen J, Ploug UJ. The cost of diabetes-related complications: registry-based analysis of days absent from work. Econ Res Int. 2013 Mar 06;2013:618039.
   Google Scholar
• Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018 Aug 16;379(7):633–644.
   PubMed Web of Science ®Google Scholar
• Gaede P, Oellgaard J, Carstensen B, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016 Nov;59(11):2298–2307.
   PubMed Web of Science ®Google Scholar
• Gaede J, Oellgaard J, Ibsen R, et al. A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study. Diabetologia. 2019 Jan;62(1):147–155.
   PubMed Web of Science ®Google Scholar
• Peña-Longobardo LM, Oliva-Moreno J, Zozaya N, et al. Economic evaluation of a multimodal intervention in pre-frail and frail older people with diabetes mellitus: the MID-FRAIL project. Expert Rev Pharmacoecon Outcomes Res. 2020 May 25:1–8. DOI:10.1080/14737167.2020.1766970.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Sánchez B, Angelini V, Feenstra T, et al. Diabetes-associated factors as predictors of nursing home admission and costs in the elderly across Europe. J Am Med Dir Assoc. 2017 Jan;18(1):74–82.
   PubMed Web of Science ®Google Scholar